Eurofarma Deal History & Licensing Activity
Eurofarma is a large pharma headquartered in Brazil. The company currently has 8 active clinical trials, primarily in Cardiovascular.
Deals (12mo)
3
Active Trials
8
Top Modality
N/A
Focus Area
Cardiovascular
Eurofarma Pipeline Focus
Therapeutic areas and modalities where Eurofarma is most active based on deal history and clinical trial data.
Therapeutic Areas
Eurofarma Strategic Signals
Key indicators of Eurofarma's licensing and acquisition strategy, including patent expirations, pipeline gaps, and strategic priorities.
Strategic Profile
Acquisition Appetite
Strategic Priorities
Eurofarma Clinical Pipeline
Eurofarma has 8 active clinical trials across 3 development phases.
1
Not Applicable
1
Phase 4
6
Phase 3
See How Your Asset Matches Eurofarma's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Cardiovascular assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Cardiovascular Deal Benchmarks
Market sizing, deal terms, and competitive landscape for cardiovascular
Dermatology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for dermatology
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Eurofarma Licensing & Deal Activity
Eurofarma is a large pharma company based in Brazil that has been actively engaged in licensing transactions across the biopharma landscape.
Key therapeutic areas of focus for Eurofarma include Cardiovascular (1 deal and trial), Autoimmune (1 deal and trial), Dermatology (1 deal and trial), and CNS Disorders (1 deal and trial).
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Eurofarma and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Eurofarma's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.